Core-funded radiotherapy trials infrastructure with central quality assurance
Radiotherapy trials need physicists to check every plan and central review of every target drawn, which nobody pays for. Fund that infrastructure permanently so trials are faster and results are trustworthy.
A national or international radiotherapy trials infrastructure providing centralised contouring review, plan quality assurance, dosimetry audit, imaging and outcome data platforms and statistical support to academic radiotherapy trials, with core funding rather than per-trial grants. The UK's RTTQA group and CTRad, NRG's IROC and EORTC's RTQA show the model; their capacity limits how many trials can run. Quality assurance is the difference between radiotherapy trials that change practice (CHHiP, PACE, FAST-Forward) and those that fail from protocol deviation, which has measurably worsened outcomes in several past trials.
- Surgery and radiotherapy cure most, get least · Surgery and radiotherapy cure more people than drugs do, but attract a fraction of the research investment.
- Trial design, endpoints and cost · A phase 3 trial takes years and hundreds of millions of dollars, and often answers a question that has already moved on.
Pages like this
not linked directly; found by shared links- IdeaCoverage-with-evidence registries for MR-guided and adaptive radiotherapy
Shares A regulatory pathway for new radiotherapy techniques modelled on drug development, MR-guided adaptive radiotherapy, SBRT / SABR (stereotactic radiotherapy), Surgery and radiotherapy cure most, get least.
- InstitutionEuropean Society for Radiotherapy and Oncology
Shares Uwe Oelfke, MR-guided adaptive radiotherapy, SBRT / SABR (stereotactic radiotherapy), Surgery and radiotherapy cure most, get least.
- InstitutionAmerican Society for Radiation Oncology
Shares MR-guided adaptive radiotherapy, NRG Oncology, SBRT / SABR (stereotactic radiotherapy), Surgery and radiotherapy cure most, get least.
- InstitutionNCT/UCC Dresden – University Hospital Carl Gustav Carus
Shares Michael Baumann, Heidelberg University Hospital / NCT / DKFZ, IMRT / IGRT (modern external beam).
- InstitutionThe Royal Marsden
Shares Uwe Oelfke, A statutory minimum share of public trial money for surgery and radiotherapy, MR-guided adaptive radiotherapy, The Institute of Cancer Research.
- CompanyElekta
Shares Validate and reimburse AI contouring and planning to expand radiotherapy capacity, MR-guided adaptive radiotherapy, SBRT / SABR (stereotactic radiotherapy), Surgery and radiotherapy cure most, get least.
- IdeaBlended finance and a low-cost linac to close the global radiotherapy gap
Shares Validate and reimburse AI contouring and planning to expand radiotherapy capacity, Surgery and radiotherapy cure most, get least, IMRT / IGRT (modern external beam).
- TechnologyFLASH radiotherapy
Shares A coordinated FLASH radiotherapy evidence programme with shared dose-rate standards, A regulatory pathway for new radiotherapy techniques modelled on drug development, Surgery and radiotherapy cure most, get least.